Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1978-11-29
1981-02-17
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544237, 544116, C07D23730
Patent
active
042515289
ABSTRACT:
This invention relates to enzyme inhibitory, novel phthalazin-4-ylacetic acid derivatives of the general formula I: ##STR1## and pharmaceutically acceptable salts as appropriate, to pharmaceutical compositions thereof, and to analogy processes for their manufacture. The compounds of formula I are inhibitors of the enzyme aldose reductase in vivo and as such may be useful in the reduction or prevention of the development of the peripheral effects such as macular oedema, cataract, retinopathy or impaired neural conduction. A preferred compound is 2-(2-fluoro-4-bromobenzyl)-1,2-dihydro-1-oxophthalazin-4-ylacetic acid.
REFERENCES:
patent: 3864343 (1975-02-01), Inoue et al.
Jour. Khim. Farm. Zh., vol. 4, pp. 22-26 (1970).
Chem. Abstracts, vol. 73, p. 366 (77173y) 1970.
Brittain David R.
Wood Robin
Imperial Chemical Industries Limited
Rizzo Nicholas S.
LandOfFree
Phthalazin-4-ylacetic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phthalazin-4-ylacetic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phthalazin-4-ylacetic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2262364